Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry

A J Saah1, C Spruill, D R Hoover

  • 1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA.

Insights

The TRAx enzyme-linked immunosorbent assay is an acceptable method for measuring helper T-lymphocyte counts. Recalibration is recommended for improved accuracy below 200 cells/µL.

Area of Science:

  • Immunology
  • Clinical Diagnostics
  • Assay Development

Background:

  • Helper T-lymphocyte (CD4+) counts are critical for monitoring immune status, particularly in HIV infection.
  • Accurate enumeration of T-lymphocytes is essential for guiding therapeutic interventions.
  • Novel diagnostic assays require rigorous validation against established methods.

Purpose of the Study:

  • To evaluate the performance of a new enzyme-linked immunosorbent assay (ELISA) system, TRAx, for quantifying helper T-lymphocyte counts.
  • To compare the results obtained from the TRAx ELISA with those from flow cytometry, a standard method.

Main Methods:

  • A cohort of 111 human immunodeficiency virus-infected injection drug users was studied.
  • Helper T-lymphocyte counts were determined using both flow cytometry and duplicate runs of the TRAx ELISA.
  • Statistical analysis included correlation coefficients and cross-tabulation to assess agreement.

Main Results:

  • The TRAx ELISA demonstrated high correlation with flow cytometry (r = .93 and .91).
  • Agreement between TRAx and flow cytometry was substantial for counts >200 cells/µL (71-90%).
  • Performance at counts ≤200 cells/µL showed variability (41-73% agreement).

Conclusions:

  • The TRAx ELISA system is a viable option for helper T-lymphocyte measurement.
  • Recalibration of the TRAx ELISA is necessary to enhance accuracy for low T-cell counts (<200 cells/µL).
  • Further optimization may improve its utility in clinical settings with low lymphocyte counts.
Abstract